MedTrace Logo

PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria

NCT07733440 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2026-07-29

No results posted yet for this study

Summary

This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population.

The main questions the validation study aims to answer are:

1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer?
2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer?

The main questions the intervention study aims to answer is:

Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement?

The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes

Conditions

  • Prostate Cancer
  • Risk Assessment
  • Clinical Decision Support Systems
  • Predictive Value of Tests
  • Models
  • Algorithms
  • Evidence-Based Practice
  • Implementation Research
  • Community Health Services
  • Primary Health Care
  • Biomarker
  • Prostate Specific Antigen
  • Global Health
  • Africa
  • Nigeria

Interventions

OTHER

(a) Training and (b) Supported risk assessment

1. The training intervention will be facilitated by experienced clinical mentors through didactics and demonstrations and conducted as half-day sessions over 3 days 2. This intervention includes risk calculator use and clinical mentorship for at least six months.

Sponsors & Collaborators

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • Ahmadu Bello University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2029-03-31
Primary Completion
2029-08-31
Completion
2029-08-31

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07733440 on ClinicalTrials.gov